Wellington Management Group
ELDN icon

Wellington Management Group’s Eledon Pharmaceuticals ELDN Stock Holding History

Wellington Management Group’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+51,011
New +$185K ﹤0.01% 1897
2025
Q4 		– Sell
-1,283,939
Closed -$3.33M – 1962
2025
Q3 		$3.33M Buy
+1,283,939
New +$3.75M ﹤0.01% 1520
2025
Q2 		– Sell
-188,485
Closed -$639K – 1971
2025
Q1 		$639K Buy
+188,485
New +$776K ﹤0.01% 1791

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Wellington Management Group's ELDN Position: Q2 2026 in Review

Wellington Management Group opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 51,011 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #1897 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in ELDN as recently as Q3 2025.

Wellington Management Group first reported a position in ELDN in Q1 2025 and has held it in 3 quarters since. The position peaked at $3.33M in Q3 2025. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Wellington Management Group held 51,011 shares of Eledon Pharmaceuticals worth $201K as of Q2 2026.
  • Eledon Pharmaceuticals was a new Wellington Management Group position in Q2 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1897 holding.
  • Wellington Management Group first reported a position in Eledon Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • Wellington Management Group's Eledon Pharmaceuticals position peaked at $3.33M in Q3 2025.
  • 161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.